Rib fracture after 177 patients with Hiroshi Onishi, Hiroshi Onishi, Rihito Tominaga, Marino, Takafumi Komiyama, Kengo University of Yamanashi,

Slides:



Advertisements
Similar presentations
Pulmonary Stereotactic Ablative Radiotherapy:
Advertisements

Commissioning an Anthropomorphic Spine and Lung Phantom for Remote Dose Verification of Institutions Participating in RTOG 0631 Douglas Caruthers, M.S.;
Dr.Sandeep.M Junior resident Dr.Ajaykumar Prof & HOD.
10th Annual Lung Cancer Conference Radiation Oncology
Multidisciplinary approaches on chest tumors Radiation Oncology Case Reports.
Evaluation of Femur Fracture Risk in Soft-Tissue Sarcoma of the Thigh Treated with Intensity- Modulated Radiation Therapy (IMRT) Michael R. Folkert, MD.
DEOEC Institute of Oncology Department of Radiotherapy.
Stereotactic Body Radiation Therapy (SBRT): The optimal indication for operable tumors in inoperable patients D.Katsochi 1, S.Kosmidis 1, A.Fotopoulou.
The Health Roundtable 1-1b_HRT1215-Session_HEGI_JOHNSON_WESTMEAD_NSW Volumetric Modulated Arc Therapy for Stereotactic Body Radiotherapy in Early Lung.
Radiotherapy Planning for Esophageal Cancers Parag Sanghvi, MD, MSPH 9/12/07 Esophageal Cancer Tumor Board Part 1.
A Propensity-matched Study of Lobectomy Versus Segmentectomy for Radiologically Pure Solid Small-sized Non-small Cell Lung Cancer Terumoto Koike 1, Seijiro.
PREOPERATIVE HYPOFRACTIONED RADIOTHERAPY IN LOCALIZED EXTREMITY/TRUNK WALL SOFT TISSUE SARCOMAS EARLY STUDY RESULTS Hanna Kosela; Milena Kolodziejczyk;
Prof Ramesh S Bilimagga President AROI Group Medical Director - HCG.
Results The measured-to-predicted dose ratio criteria used by the RPC to credential institutions is , however for this work, a criteria of
بسم الله الرحمن الرحيم و قل رب زدنى علماً ﴿و قل رب زدنى علماً﴾ صدق الله العظيم.
Stereotactic body radiation therapy for T1N0M0 non-small cell lung cancer. First report for inoperable population of a phase II trial by Japan Clinical.
Dosimetric Evaluation of Planning Techniques in Lung SBRT
Conformal Therapy for Lung Cancer B. Schicker, F.J. Schwab*, U. Götz Institute of Radiotherapy and Radiation Oncology St. Vincenz-Krankenhaus Limburg *Clinic.
Vertebral Fractures After Stereotactic Ablative Radiotherapy of Lung Tumors Todd A. Aguilera MD PhD 1, Nicholas Trakul MD PhD 2, David B. Shultz MD PhD.
Comparison of Rectal Dose Volume Histograms for Definitive Prostate Radiotherapy Among Stereotactic Radiotherapy, IMRT, and 3D-CRT Techniques Author(s):
Advances in Thoracic Radiation Therapy Shilpen Patel MD, FACRO Department of Radiation Oncology, University of Washington, Seattle, WA.
Cardiac events after treatment with high dose radiation therapy +/- chemotherapy for non-small cell lung cancer Linglong Tang, Anwen Liu, Daniel Gomez,
Decreased Risk of Radiation Pneumonitis With Coincident Concurrent Use Of Angiotensin- Converting Enzyme Inhibitors In Patients Receiving Lung Stereotactic.
Application of a 2-D ionization chamber array for dose verification of dynamic IMRT with a micro-MLC Fujio ARAKI, PhD 1, S. TAJIRI 2, H. TOMINAGA 2, K.
S L I D E 0 Elderly Patients Undergoing SBRT for Inoperable Early Stage NSCLC Achieve Similar Outcomes to Younger Patients Brandon R. Mancini, Henry S.
Institute for Advanced Radiation Oncology
We retrospectively analyzed 58 patients with ONSM treated between on a dedicated 6 MV stereotactic LINAC. All cases were discussed in a multidisciplinary.
Title: Stereotactic Ablative Radiotherapy (SABR) can be Safe and Effective for Treatment of Central and Ultra-Central Lung Tumors. Author: Aadel Chaudhuri,
Michael Brada Torino 6 March 2015 Perspectives in lung cancer Stereotactic ablative radiation therapy (SABR) in patients with inoperable NSCLC.
Conflict of Interest Declaration: Nothing to Disclose Presenter: Sophie Lamoureux Title of Presentation: A Comparison of Stereotactic Body Radiotherapy.
. Background Paclitaxel and Irinotecan in Platinum Refractory or Resistant Small Cell Lung Cancer: a Galician Lung Cancer.
Outcomes of Stereotactic Ablative Radiotherapy (SABR) for a Second Primary Lung Cancer (SPLC): Evidence in Support of Routine CT Surveillance C. J.A. Haasbeek,
Approaching early stage disease
Tumor Location Correlates with Radiation Pneumonitis after Stereotactic Body Radiation Therapy (SBRT) for Primary and Oligometastatic Lesions of the Lung.
Palliative Single 8 Gy Radiotherapy for Symptomatic Aggressive Lymphomas 2666 A -408 Oguchi M, Eba J, Tanaka O, Kozuka T, Murofushi K, Toshiyasu T, Tsurugai.
Increased Local Control of Lung and Liver Tumors Associated with Dose-Escalated Stereotactic Body Radiation Therapy (SBRT) Supports a Dose-Response Relationship.
SARC018: A SARC PILOT MULTICENTER STUDY OF PREOPERATIVE RADIATION AND SURGERY IN PATIENTS WITH HIGH- RISK DESMOID TUMORS Robert S. Benjamin, M.D.
 Multidisciplinary Effort › Surgery › Radiation › Systemic Rx (chemo, “drugs”)
Carmel McDerby Clatterbridge Centre for Oncology, Merseyside,UK
UNIVERSAL SURVIVAL CURVE AND SINGLE FRACTION EQUIVALENT DOSE: USEFUL TOOLS IN UNDERSTANDING POTENCY OF ABLATIVE RADIOTHERAPY CLINT PARK, M.D. M.S., LECH.
THE IMPLEMENTATION OF ABLATIVE HYPOFRACTIONATED RADIOTHERAPY FOR STEREOTACTIC TREATMENTS IN THE BRAIN AND BODY: OBSERVATIONS ON EFFICACY AND TOXICITY IN.
PHASE II TRIAL OF HYPOFRACTIONATED BREAST IRRADIATION WITH VMAT-SIB TECHNIQUE: TOXICITY AND EARLY CLINICAL ASSESSMENT IN 270 PATIENTS F. De Rose¹, F. Alongi¹,
방사선종양학과 - 혈액종양내과 Joint Conference 경희의료원 방사선종양학과 R4 공 문 규.
Emily Tanzler, MD Waseet Vance, MD
Dr. Malhar Patel DNB (Radiation Oncology)
Understanding Radiation Therapy Lecturer Radiological Science
Kasey Etreni BSc., MRT(T), RTT, CTIC
Hypofractionated radiotherapy for breast cancer
Rationale in the Single Session Treatment of Lung Tumors
Compassionate People World Class Care
Jeffrey Bradley, MD  Journal of Thoracic Oncology 
Treatment With Continuous, Hyperfractionated, Accelerated Radiotherapy (CHART) For Non-Small Cell Lung Cancer (NSCLC): The Weston Park Hospital Experience.
Evaluation Of RTOG Guidelines For Monte Carlo Based Lung SBRT Planning
Image–Guided Radiation Therapy for Non–small Cell Lung Cancer
Colorectal SSG: SABR and Oligometastatic Disease
Reducing Treatment Time and MUs by using Dynamic Conformal Arc Therapy for SBRT Breath-Hold Patients Timothy Miller, Sebastian Nunez Albermann, Besil Raju,
L. A. den Otter. , R. M. Anakotta. , M. Dieters. , C. T. Muijs. , S
Severe Local Toxicity after Lung Stereotactic Body Radiation Therapy: Lesional Abscess Leading to Bronchocutaneous Fistula Requiring Surgical Marsupialization 
A Multi-Institutional Dosimetric Evaluation of Proton Versus Photon Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma F. Khan, B. Nguyen,
Image–Guided Radiation Therapy for Non–small Cell Lung Cancer
Figure 4 Treatment plans using stereotactic body radiotherapy (SBRT)
Cornelis J. A. Haasbeek, MD, PhD, Frank J. Lagerwaard, MD, PhD, Ben J
Stereotactic Ablative Radiotherapy for Centrally Located Early Stage Non–Small-Cell Lung Cancer: What We Have Learned  Joe Y. Chang, MD, PhD, Andrea Bezjak,
Chest Wall Pain and Rib Fracture after Stereotactic Radiotherapy for Peripheral Non- small Cell Lung Cancer  Jon-Paul J. Voroney, PhD, MD, Andrew Hope,
Hypofractionated Stereotactic Radiotherapy (HypoFXSRT) for Stage I Non-small Cell Lung Cancer: Updated Results of 257 Patients in a Japanese Multi-institutional.
Incidence and Risk Factors for Chest Wall Toxicity After Risk-Adapted Stereotactic Radiotherapy for Early-Stage Lung Cancer  Eva M. Bongers, MD, Cornelis.
B5-05: Frameless stereotactic body radiotherapy using four dimensional cone beam CT guidance  Jan-Jakob Sonke, Jose Belderbos, Maddalena Rossi, Jochem.
Stereotactic Body Radiation Therapy for Primary Lung Cancers >3 Centimeters  John J. Cuaron, MD, Ellen D. Yorke, PhD, Amanda Foster, BA, Meier Hsu, MS,
Jeffrey Bradley, MD  Journal of Thoracic Oncology 
GHG meeting at ESTRO36 May, 2017
Presentation transcript:

Rib fracture after 177 patients with Hiroshi Onishi, Hiroshi Onishi, Rihito Tominaga, Marino, Takafumi Komiyama, Kengo University of Yamanashi,

stereotactic body stage I non-small Tsuyota Koshiishi, Shinichi Aoki. Kuriyama, Eiichi Sawada, Atsushi Yamanashi, Japan

radiotherapy in cell lung cancer Masayuki Araya, Ryo Saito, Kan Nambu, Naoki Sano, Tsutomu Araki

Background Despite the increasing popularity of SBRT, experience with extremely hypofractionated, high-dose radiotherapy regimens and their posttreatment radiologic findings and clinical toxicity remains limited. Multiple Phase I and II SBRT studies of the treatment of Stage I-II NSCLC have reported chest wall (CW) pain and/or rib fracture as a part of the toxicity profile. But an exact frequency of rib fracture after SBRT and risk factors for it was unknown.

Purpose The aim of the study was to assess the relationship between the background of factors in patients or the treatment and the development of rib fracture*. * Definition of the rib fracture in the study : A CT findings of linear line indicating fracture on rib on high dose-irradiated area

Total cases Age Stage Tumor diameter Distance to chest wall 177 (male 132, female 45) (median 78) years T1N0M0 118, T2N0M (median 25) mm 0-53 (median 6) mm Patients characteristics Irradiated from to Dose and prescription Total dose / fractionations/ days 40Gy / 10 fr / 4-7 days 48 Gy / 4 fr / 4-7 days 60 Gy / 10 fr / 5-8 days 70 Gy / 10 fr / 5-8 days BED(  =3Gy) 93.3 Gy 240 Gy 180 Gy Gy Prescription D95(PTV) Isocenter D95(PTV)

SBRT planning 1)Instruct patient to reproduce patients’ self-judged breath-holds according to a respiratory indicator (ABCHES). 2) Measurement of reproducibility of the patient’s self-inspired breath-hold by 3 times of CT scanning 3)Three dimensional (3D) treatment planning was performed. Planning target volume (PTV) was defined as gross tumor volume (GTV) + reproducibility of the patient’s self-breath-hold + 5mm safety margin. 4)Port margin around PTV 5mm in the protocol of 48Gy/4fr 0mm in the protocol of 60Gy/10fr and 70Gy/10fr 5)Beams: 6MV-X ray, non-coplanar multiple (>6) static ports or multiple (>400 degrees) dynamic arcs 6)Calculation algorithm: Clarkson or Convolution 7)Heterogeneity correction (+)

The treatment procedure In every fraction 1)Reassurance of reproducibility of patients’ self-breath-holds 2)Adjustment of the isocenter of the PTV to the planned position using CT- linac system under patients’ self-judged breath hold according to a respiratory indicator (ABCHES). 3)Irradiation performed under patients’ self-breath-holds 4)The tumor position in the irradiation port during irradiation was monitored with a real-time electronic portal imaging device (EPID) 5)The tumor position was verified using CT just after irradiation 【 CT 】 【 Symptom (pain) 】 SBRT Following up examination ( months after SBRT)

Analysis ①Time duration to detection of rib fracture ②Clinical symptom (pain) ③Comparison between cases with fracture (+) versus (-) a. Distance between tumor and chest wall b. Patient characteristics c. CT findings of chest wall d. Maximum dose of the rib

Results  Positive rib fracture (+) : 41 cases  No rib fracture (-) for more than 24 months until the last follow-up : 46 cases 40Gy / 4 fr / 4-7 days 48 Gy / 4 fr / 4-7 days 60 Gy / 10 fr / 5-8 days 70 Gy / 10 fr / 5-8 days T1 T2 Fracture (+)Fracture (-) 0 / 1 (0.0%) 16 / 37 (43.2%) 14 / 34 (41.2%) 11 / 15 (73.3%) 25 / 61 (41.0%) 16 / 26 (61.5%) 1 / 1 (100.0%) 21 / 37 (56.8%) 20 / 34 (58.8%) 4 / 15 (26.7%) 36 / 61 (59.0%) 10 / %)

Time duration from SRT to detection of rib fracture Median : 15 months Mean : 16.8 months Cases number Time duration (months)

Pain*Fractute (+)(n=41)Fracture (-)(n=46) Grade 027/41(65.9%)39/46(84.8%) Grade 17/41(17.1%)4/46(8.7%) Grade 27/41(17.1%)3/46(7.7%) Grade 30/41(0%)0/46(0%) *CTCAE(Common Terminology Criteria for Adverse Events) v3.0 Clinical symptom (pain )

Distance between tumor and chest wall (mm) 16mm Fracture (-)Fracture (+) Comparison between cases with fracture (+) versus (-) Distance between tumor and chest wall

Fracture (+)(n=41)Fracture(-)(n=46) Age Mean 76.9 (64-89) Mean78.5 (61-91) Gender * male: female 24 : 1736 : 10 * p < 0.05 (chi-square test) Comparison between cases with fracture (+) versus (-) Patient characteristics

Fracture (+) (n=41)Fracture (-) (n=46) Chest wall edema 35(85.4%)10(21.7%) Thinning or erosion of the rib 30(73.2%)6(13.0%) Comparison between cases with fracture (+) versus (-) CT findings

Case 24 カ月後 86 y.o. female adenoca,T2N0M0 70Gy/10fr 24 months after 6 months after Chest wall edema and thinning of rib cortex Rib fracture

Risk factor* for rib fracture Odds ratio 95% confidential interval Age Gender(Female) Distance between tumor and chest wall * Stepwise Logistic regression anlysis

Fracture (+)(n=9)Fracture (-)(n=8) Maximum chest wall dose (BED Gy) ± ± 76.1 Comparison between cases with fracture (+) versus (-) Maximum dose in chest wall ( in 17 cases in which detailed dose was calculated) * *  = 3 Gy p<0.01 t-test

Fracture (+) (BED Gy) Comparison between cases with fracture (+) versus (-) Maximum chest wall dose (BED)  = 3 Gy Fracture (-)

ROC analysis Chest wall maximum BED = 225.5Gy Sensiivity = Specificity= 0.11 Sensitivity (1-specificity) Comparison between cases with fracture (+) versus (-) Maximum chest wall dose (BED)

Fracture (-) Fracture (+) (Gy) 225.5Gy Likelihood ration=sensitivity/ (1-specificity )= 0.71/0.11=6.45 Comparison between cases with fracture (+) versus (-) Maximum chest wall dose (BED)

1.J. Thorac Oncol 2009:4: Int J Radiat Oncol Biol Phys 2010; 76: Radiotherapy and Oncology 2009;91: Lung Cancer 2005;48: Lung Cancer 2008;60: Lung Cancer 2006;51: Author Total Dose (Gy) High risk factors Voloney(1) Dunlap(2) Pettersson(3) Zimmermann4) Fritz(5) Nyman(6) – Distance to chest wall < 2cm, Median dose = 46.4Gy /3fr Chest wall volume receiving > 30Gy 2mL of rib received > 40Gy not demonstrated 9 (21.4%) 5 (8.3%) 7 (10.3%) 1 (3 %) 2 (5 %) 4 (8.9%) Fractions number No. of patients Chest wall complications including rib fracture in previous literatures Rib fracture

Conclusion  Rib fracture after SBRT for lung cancer was produced in 41 of 177 cases (23.2%).  Female and short distance between the tumor and the chest wall were risk factors for production of rib fracture.  The distance between the tumor and the chest wall was under 16mm in all rib fracture cases.  Maximum BED(  =3Gy) of the chest wall in all rib fracture cases was over 200Gy